Stock SNG SYNAIRGEN PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Synairgen plc

Equities

SNG

GB00B0381Z20

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 09:05:17 08/05/2024 pm IST 		5-day change 1st Jan Change
5.76 GBX -2.54% Intraday chart for Synairgen plc -7.10% -3.60%
07/05 AstraZeneca target raised; Antofagasta lowered AN
2023 FTSE 100 Finishes Slightly Lower After Steady Session DJ

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 14.5 6.429 305.9 418.8 27.19 11.6 11.6 -
Enterprise Value (EV) 1 9.166 3.975 231 385 11.26 0.7862 6.097 9.408
P/E ratio -3.82 x -1.65 x -16.2 x -8.57 x -1.54 x -1.29 x -1.93 x -3.87 x
Yield - - - - - - - -
Capitalization / Revenue 13,80,94,581 x - - - - - - -
EV / Revenue 8,72,94,581 x - - - - - - -
EV / EBITDA -2.29 x -0.86 x -13.3 x -6.73 x -0.58 x -0.07 x -0.9 x -2.47 x
EV / FCF -21,77,698 x -13,67,933 x -96,18,262 x -93,82,272 x -7,87,827 x - - -
FCF Yield -0% -0% -0% -0% -0% - - -
Price to Book 2.09 x 2.85 x 3.59 x 11.3 x - 1.01 x 1.89 x 4.1 x
Nbr of stocks (in thousands) 1,09,433 1,09,433 1,99,914 2,01,342 2,01,375 2,01,375 2,01,375 -
Reference price 2 0.1325 0.0588 1.530 2.080 0.1350 0.0576 0.0576 0.0576
Announcement Date 25/02/19 26/05/20 12/05/21 25/05/22 27/04/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 0.105 - - - - - - -
EBITDA 1 -3.994 -4.61 -17.44 -57.16 -19.28 -10.8 -6.805 -3.805
EBIT -4.034 -4.706 -17.53 -57.36 -19.38 - - -
Operating Margin -3,841.9% - - - - - - -
Earnings before Tax (EBT) 1 -4.096 -4.793 -17.73 -57.86 -20.09 -11 -7 -4
Net income 1 -3.301 -3.885 -13.92 -48.66 -17.64 -9 -6 -3
Net margin -3,143.81% - - - - - - -
EPS 2 -0.0347 -0.0355 -0.0946 -0.2428 -0.0876 -0.0447 -0.0298 -0.0149
Free Cash Flow -4.209 -2.906 -24.02 -41.03 -14.29 - - -
FCF margin -4,008.57% - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 25/02/19 26/05/20 12/05/21 25/05/22 27/04/23 - - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - - -
Net Cash position 1 5.33 2.45 74.8 33.8 15.9 10.8 5.5 2.19
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -4.21 -2.91 -24 -41 -14.3 - - -
ROE (net income / shareholders' equity) -50.9% -91.7% -31.8% -79% -61.6% -56.7% -68.2% -66.9%
ROA (Net income/ Total Assets) - - - - - -47% -49.8% -38.8%
Assets 1 - - - - - 19.14 12.05 7.74
Book Value Per Share 2 0.0600 0.0200 0.4300 0.1800 - 0.0600 0.0300 0.0100
Cash Flow per Share 2 - - - - - -0.0400 -0.0300 -0.0200
Capex - 0.01 0.04 0.02 0.01 - - -
Capex / Sales - - - - - - - -
Announcement Date 25/02/19 26/05/20 12/05/21 25/05/22 27/04/23 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0591 GBP
Average target price
0.08 GBP
Spread / Average Target
+35.36%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SYNAIRGEN PLC Stock Synairgen plc
-3.60% 14.93M
MODERNA, INC. Stock Moderna, Inc.
+22.56% 46.4B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.51% 41.75B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.37B
CELLTRION, INC. Stock Celltrion, Inc.
-3.42% 29.71B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.13% 26.01B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.44% 19.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.45% 12.43B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-0.14% 12.18B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.47% 12.13B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SNG Stock
  4. Financials Synairgen plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW